Cargando…
Duodenal Recurrence of Fibrolamellar Carcinoma 12 Years After Partial Hepatectomy and Adjuvant Chemotherapy
Fibrolamellar carcinoma (FLC) has a better prognosis than hepatocellular carcinoma; however, it is a highly recurrent disease. A 17-year-old woman presented with FLC with regional disease at the right lobe of the liver and underwent right hepatic lobe resection plus adjuvant chemotherapy with interf...
Autores principales: | Díaz Hernández, Héctor Adrián, Gómez Ruiz, Ismael Antonio, Torre, Aldo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Gastroenterology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126493/ https://www.ncbi.nlm.nih.gov/pubmed/27921059 http://dx.doi.org/10.14309/crj.2016.133 |
Ejemplares similares
-
Fibrolamellar hepatocellular carcinoma presenting with early recurrent thrombosis
por: Kundakcioglu, Hacer, et al.
Publicado: (2022) -
Atezolizumab and Bevacizumab Combination Therapy and Sequential Conversion Hepatectomy for Advanced Fibrolamellar Hepatocellular Carcinoma Presenting Pseudoprogression
por: Matsuki, Ryota, et al.
Publicado: (2022) -
DWI-based radiomic signature: potential role for individualized adjuvant chemotherapy in intrahepatic cholangiocarcinoma after partial hepatectomy
por: Yang, Yang, et al.
Publicado: (2022) -
Clinical and pathologic factors associated with survival in young adult patients with fibrolamellar hepatocarcinoma
por: Moreno-Luna, Laura E, et al.
Publicado: (2005) -
Fibrolamellar Carcinoma: 2012 Update
por: Torbenson, Michael
Publicado: (2012)